Approval · Notice of Compliance 7646 · 2005
ESTRACE: Notice of Compliance 7646
Issued December 7, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7646
- Date
- December 7, 2005
- Company
- Shire Biochem Inc.Saint Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Information from the whi trial for estrace and new pm format
- Therapeutic class
- Estrogen
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ESTRACE | Not yet assigned | — |